BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23696612)

  • 21. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
    Hawkins NM; Wang D; McMurray JJ; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG;
    Eur J Heart Fail; 2007 May; 9(5):510-7. PubMed ID: 17317308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
    Komajda M; Tavazzi L; Francq BG; Böhm M; Borer JS; Ford I; Swedberg K;
    Eur J Heart Fail; 2015 Dec; 17(12):1294-301. PubMed ID: 26377342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structural-functional peculiarities of the heart and survival of elderly patients with chronic heart failure and left bundle branch block].
    Larina VN; Bart BIa
    Kardiologiia; 2009; 49(5):16-21. PubMed ID: 19463129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
    Ekman I; Chassany O; Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Swedberg K
    Eur Heart J; 2011 Oct; 32(19):2395-404. PubMed ID: 21875859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT.
    Mascioli G; Padeletti L; Sassone B; Zecchin M; Lucca E; Sacchi S; Boggian G; Tondo AL; Belvito C; Bakhtadze N; Borrelli A; Sinagra G
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):927-34. PubMed ID: 22651702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry.
    Aleksova A; Carriere C; Zecchin M; Barbati G; Vitrella G; Di Lenarda A; Sinagra G
    Europace; 2014 Oct; 16(10):1450-9. PubMed ID: 24550348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concordant versus discordant left bundle branch block in heart failure patients: novel clinical value of an old electrocardiographic diagnosis.
    Padeletti L; Valleggi A; Vergaro G; Lucà F; Rao CM; Perrotta L; Cappelli F; L'Abbate A; Passino C; Emdin M
    J Card Fail; 2010 Apr; 16(4):320-6. PubMed ID: 20350699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
    Böhm M; Lloyd SM; Ford I; Borer JS; Ewen S; Laufs U; Mahfoud F; Lopez-Sendon J; Ponikowski P; Tavazzi L; Swedberg K; Komajda M
    Eur J Heart Fail; 2016 Jun; 18(6):672-83. PubMed ID: 26952245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL; Bobadilla RV
    J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system.
    Fantoni C; Kawabata M; Massaro R; Regoli F; Raffa S; Arora V; Salerno-Uriarte JA; Klein HU; Auricchio A
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):112-9; discussion 120-1. PubMed ID: 15720446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
    Komajda M; Böhm M; Borer JS; Ford I; Robertson M; Manolis AJ; Tavazzi L; Swedberg K;
    Eur J Heart Fail; 2014 Jul; 16(7):810-6. PubMed ID: 24961493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure.
    Barsheshet A; Leor J; Goldbourt U; Garty M; Schwartz R; Behar S; Luria D; Eldar M; Glikson M
    Am J Cardiol; 2008 May; 101(9):1303-8. PubMed ID: 18435962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and predictors of heart failure hospitalization and death in permanent pacemaker patients: a single-centre experience over medium-term follow-up.
    Mazza A; Bendini MG; Leggio M; Riva U; Ciardiello C; Valsecchi S; De Cristofaro R; Giordano G
    Europace; 2013 Sep; 15(9):1267-72. PubMed ID: 23444421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients.
    Mazza A; Bendini MG; Leggio M; Imberti JF; Valsecchi S; Boriani G
    J Cardiovasc Med (Hagerstown); 2024 Jul; 25(7):551-558. PubMed ID: 38809231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bundle branch block patterns and long-term outcomes in heart failure.
    Abdel-Qadir HM; Tu JV; Austin PC; Wang JT; Lee DS
    Int J Cardiol; 2011 Jan; 146(2):213-8. PubMed ID: 20202707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure.
    Castro P; Winter JL; Verdejo H; Orellana P; Quintana JC; Greig D; Enríquez A; Sepúlveda L; Concepción R; Sepúlveda P; Rossel V; Chiong M; García L; Lavandero S
    J Heart Lung Transplant; 2012 Oct; 31(10):1096-101. PubMed ID: 22975099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
    Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.